A detailed history of Mcmillion Capital Management Inc transactions in Amgen Inc stock. As of the latest transaction made, Mcmillion Capital Management Inc holds 14 shares of AMGN stock, worth $3,970. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14
Holding current value
$3,970
% of portfolio
0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 08, 2023

BUY
$214.27 - $253.37 $2,999 - $3,547
14 New
14 $3,000
Q2 2022

Aug 03, 2022

BUY
$230.71 - $256.74 $3,229 - $3,594
14 New
14 $3,000
Q1 2021

May 13, 2021

SELL
$221.91 - $258.6 $17,974 - $20,946
-81 Closed
0 $0
Q4 2020

Feb 08, 2021

BUY
$216.38 - $257.67 $17,526 - $20,871
81 New
81 $19,000
Q2 2020

Aug 06, 2020

SELL
$197.81 - $242.74 $23,737 - $29,128
-120 Closed
0 $0
Q1 2020

May 22, 2020

BUY
$182.24 - $241.7 $10,752 - $14,260
59 Added 96.72%
120 $24,000
Q2 2019

Jul 25, 2019

BUY
$166.7 - $195.41 $10,168 - $11,920
61 New
61 $11,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $152B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Mcmillion Capital Management Inc Portfolio

Follow Mcmillion Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mcmillion Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mcmillion Capital Management Inc with notifications on news.